Reply

We thank Ghajari and Sabour for their interest in our recently published article1 and for their insightful comments. We agree that our study population is limited by referral bias, as it is influenced by the regional demographics, practice standards, etc. particular to a single institution. As mentioned in the limitations section of our discussion, this cohort may not reflect all patients with hepatitis C virus (HCV) and end-stage renal disease (ESRD). The study would benefit from validation in a large multicenter trial to reduce the risk of bias and improve generalizability.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research